Tranfemoral Aortic Vavle Replacement
Conditions
Interventions
Group 1: Local anaesthesia
Group 2: Conversion
Group 3: Sedation
Sponsors
Klinik für Kardiologie, Pneumologie und Angiologie
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: All patients who underwent aortic valve replacement between 01/2022 and 02/2023
Exclusion criteria
Exclusion criteria: age below 18
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Occurence of clinically defined delirium | — |
Secondary
| Measure | Time frame |
|---|---|
| Amount and duration of sedation for TAVI Presence of delirium during the inpatient stay Duration of the delirium Need for a psychiatric consultation Need for psychotropic medication Prolonged hospital stay Length of stay in intensive care unit Laboratory chemical and echocardiographic data pre- and up to 7 days post-TAVI Long-term outcome measured by the occurrence of ischemic events (myocardial infarction, stroke), death or hospitalization for heart failure | — |
Countries
Germany
Contacts
Public ContactLisa Dannenberg
Klinik für Kardiologie, Pneumologie und Angiologie
Outcome results
None listed